Burlington, North Carolina (NC) Medicines-Patent and Proprietary Companies

Featured companies
Burlington Chc Pharmacy
1214 Vaughn Road # 201
Burlington NC 27217
(336) 506-5835
Cvs/Pharmacy
2344 South Church St.
Burlington NC 27215
(336) 227-7442
Cvs/Pharmacy
1149 University Drive
Burlington NC 27215
(336) 584-6041
Not satisfied? Select a reasonRate this pageSend feedback

Or try our search form or quick navigation by category and location

Cvs Pharmacy Inc
2017 West Webb Avenue
Burlington NC 27217
(336) 221-8860
Nc C V S Pharmacy LLC
1149 University Drive
Burlington NC 27215
(336) 584-6041
Pharaohs Pharmacy Inc
2971 Crouse Lane
Burlington NC 27215
(336) 538-0444
Psc Medsupply
3119 Lear Drive
Burlington NC 27215
(336) 227-3118
Rite Aid
2127 Chapel Hill Road
Burlington NC 27215
(336) 227-2784
Rite Aid
3465 South Church St.
Burlington NC 27215
(336) 584-3374
Rite Aid
1909 North Church St.
Burlington NC 27217
(336) 227-5506
Rite Aid Corporation
520 North Church St.
Burlington NC 27217
(336) 228-7879
Sdc
660 Lakeside Avenue
Burlington NC 27217
(336) 226-2296
Whereorg has 12 results under Medicines-Patent and Proprietary Companies in Burlington, NC.

Other categories for location Alamance, North Carolina

Other locations for category Medicines-Patent and Proprietary

Quick navigation
Subcategory
City or suburb

Top Stories
UBS flags buyback possibility after Second-quarter earnings beat
UBS , the world's largest wealth manager, on Tuesday signalled the possibility of resuming share buybacks later this year after generating more income than expected in the first six months and as it boosted...
Tue, Jul 21 2020
Greece calls EU recovery fund deal a 'national success'
Prime Minister Kyriakos Mitsotakis called a European Union deal on a post-pandemic recovery fund a "national success" that would allocate Greece around 72 billion euros ($82.38 billion) to help deal with...
Tue, Jul 21 2020
UBS second-quarter net profit dips as Swiss business dampens trading bonanza
UBS , the world's largest wealth manager, saw net profit drop 11% in the second quarter as higher trading activity failed to offset a pandemic-induced slump in retail and corporate banking.
Tue, Jul 21 2020